Myeloproliferative disorder

National Cancer Institute

1 trialPhase 2442 people

Masonic Cancer Center, University of Minnesota

1 trialPhase 2295 people

University of Liege

1 trialPhase 239 people

St. Petersburg State Pavlov Medical University

1 trialPhase 1/220 people

Stanford University

1 trialPhase 166 people